questionsmedicales.fr
États, signes et symptômes pathologiques
Processus pathologiques
Hyperbilirubinémie
Hyperbilirubinémie : Questions médicales fréquentes
Diagnostic
5
Hyperbilirubinémie
Tests de laboratoire
Bilirubine
Hyperbilirubinémie
Jaunisse
Hyperbilirubinémie
Échographie
Tests hépatiques
Hyperbilirubinémie
Asymptomatique
Symptômes
5
Démangeaisons
Hyperbilirubinémie
Douleurs abdominales
Hyperbilirubinémie
Prévention
5
Alimentation
Santé hépatique
Examens médicaux
Prévention
Traitements
5
Photothérapie
Traitement médical
Photothérapie
Hyperbilirubinémie néonatale
Transfusion sanguine
Hyperbilirubinémie
Remèdes naturels
Consultation médicale
Complications
5
Complications
Lésions hépatiques
Dommages cérébraux
Hyperbilirubinémie néonatale
Cirrhose
Hyperbilirubinémie
Infections
Troubles hépatiques
Maladies hépatiques
Complications
Facteurs de risque
5
Facteurs de risque
Maladies hépatiques
Nouveau-né
Personnes âgées
Antécédents médicaux
Anémie
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Hyperbilirubinémie : Questions médicales les plus fréquentes",
"headline": "Hyperbilirubinémie : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Hyperbilirubinémie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-30",
"dateModified": "2026-03-22",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Hyperbilirubinémie"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Processus pathologiques",
"url": "https://questionsmedicales.fr/mesh/D010335",
"about": {
"@type": "MedicalCondition",
"name": "Processus pathologiques",
"code": {
"@type": "MedicalCode",
"code": "D010335",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Hyperbilirubinémie néonatale",
"alternateName": "Hyperbilirubinemia, Neonatal",
"url": "https://questionsmedicales.fr/mesh/D051556",
"about": {
"@type": "MedicalCondition",
"name": "Hyperbilirubinémie néonatale",
"code": {
"@type": "MedicalCode",
"code": "D051556",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.429.249"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Ictère néonatal",
"alternateName": "Jaundice, Neonatal",
"url": "https://questionsmedicales.fr/mesh/D007567",
"about": {
"@type": "MedicalCondition",
"name": "Ictère néonatal",
"code": {
"@type": "MedicalCode",
"code": "D007567",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.429.249.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Ictère nucléaire",
"alternateName": "Kernicterus",
"url": "https://questionsmedicales.fr/mesh/D007647",
"about": {
"@type": "MedicalCondition",
"name": "Ictère nucléaire",
"code": {
"@type": "MedicalCode",
"code": "D007647",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.429.750"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Hyperbilirubinémie",
"alternateName": "Hyperbilirubinemia",
"code": {
"@type": "MedicalCode",
"code": "D006932",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Kara L Calkins",
"url": "https://questionsmedicales.fr/author/Kara%20L%20Calkins",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Pearl W Chang",
"url": "https://questionsmedicales.fr/author/Pearl%20W%20Chang",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatrics, Seattle Children's Hospital, Seattle, Washington; Departments of pearlchangmd@gmail.com."
}
},
{
"@type": "Person",
"name": "Claudio Tiribelli",
"url": "https://questionsmedicales.fr/author/Claudio%20Tiribelli",
"affiliation": {
"@type": "Organization",
"name": "Liver Brain Unit \"Rita Moretti\", Fondazione Italiana Fegato-Onlus, Bldg. Q, AREA Science Park, 34149 Basovizza, Italy."
}
},
{
"@type": "Person",
"name": "Rinawati Rohsiswatmo",
"url": "https://questionsmedicales.fr/author/Rinawati%20Rohsiswatmo",
"affiliation": {
"@type": "Organization",
"name": "Neonatology Division, Department of Pediatrics, Cipto Mangunkusumo Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, 10430, Indonesia."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Hyperbilirubinemia and Choledocholithiasis in an Extremely Premature Neonate.",
"datePublished": "2023-08-01",
"url": "https://questionsmedicales.fr/article/37561830",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3928/19382359-20230613-04"
}
},
{
"@type": "ScholarlyArticle",
"name": "Hyperbilirubinemia in hospitalized patients: Etiology and outcomes.",
"datePublished": "2023-06-30",
"url": "https://questionsmedicales.fr/article/37386866",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/10815589231180498"
}
},
{
"@type": "ScholarlyArticle",
"name": "Results of the Study of the Auditory Analyzer in Newborns with Hyperbilirubinemia.",
"datePublished": "2023-12-04",
"url": "https://questionsmedicales.fr/article/38050891",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.5935/0946-5448.20230015"
}
},
{
"@type": "ScholarlyArticle",
"name": "Intravenous immunoglobulin G therapy for neonatal hyperbilirubinemia.",
"datePublished": "2023-07-25",
"url": "https://questionsmedicales.fr/article/37491586",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41390-023-02712-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effect of hyperbilirubinemia and phototherapy on apoptotic microparticle levels in neonates.",
"datePublished": "2024-05-10",
"url": "https://questionsmedicales.fr/article/38973516",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/MBC.0000000000001297"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "États, signes et symptômes pathologiques",
"item": "https://questionsmedicales.fr/mesh/D013568"
},
{
"@type": "ListItem",
"position": 3,
"name": "Processus pathologiques",
"item": "https://questionsmedicales.fr/mesh/D010335"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hyperbilirubinémie",
"item": "https://questionsmedicales.fr/mesh/D006932"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Hyperbilirubinémie - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Hyperbilirubinémie",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Hyperbilirubinémie",
"description": "Comment diagnostiquer l'hyperbilirubinémie ?\nQuels sont les types de bilirubine mesurés ?\nQuels symptômes indiquent une hyperbilirubinémie ?\nQuels examens complémentaires sont utiles ?\nL'hyperbilirubinémie est-elle toujours symptomatique ?",
"url": "https://questionsmedicales.fr/mesh/D006932#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Hyperbilirubinémie",
"description": "Quels sont les symptômes courants de l'hyperbilirubinémie ?\nL'hyperbilirubinémie peut-elle causer des démangeaisons ?\nComment l'urine change-t-elle en cas d'hyperbilirubinémie ?\nPeut-on avoir des douleurs abdominales ?\nL'hyperbilirubinémie affecte-t-elle la vision ?",
"url": "https://questionsmedicales.fr/mesh/D006932#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Hyperbilirubinémie",
"description": "Comment prévenir l'hyperbilirubinémie ?\nLes vaccinations sont-elles utiles ?\nFaut-il surveiller les nouveau-nés ?\nL'alimentation joue-t-elle un rôle ?\nLes examens réguliers sont-ils importants ?",
"url": "https://questionsmedicales.fr/mesh/D006932#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Hyperbilirubinémie",
"description": "Quels traitements existent pour l'hyperbilirubinémie ?\nLa photothérapie est-elle efficace ?\nQuand faut-il envisager une transfusion sanguine ?\nLes médicaments peuvent-ils aider ?\nY a-t-il des remèdes naturels ?",
"url": "https://questionsmedicales.fr/mesh/D006932#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Hyperbilirubinémie",
"description": "Quelles complications peuvent survenir ?\nL'hyperbilirubinémie peut-elle causer des dommages cérébraux ?\nY a-t-il un risque de cirrhose ?\nPeut-elle entraîner des infections ?\nQuels sont les risques à long terme ?",
"url": "https://questionsmedicales.fr/mesh/D006932#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Hyperbilirubinémie",
"description": "Quels sont les facteurs de risque d'hyperbilirubinémie ?\nL'âge influence-t-il le risque ?\nLes antécédents médicaux jouent-ils un rôle ?\nLe sexe a-t-il un impact ?\nLes habitudes de vie influencent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D006932#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer l'hyperbilirubinémie ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un test sanguin mesure les niveaux de bilirubine pour confirmer le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les types de bilirubine mesurés ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "On mesure la bilirubine totale, directe et indirecte pour évaluer la cause."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une hyperbilirubinémie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le jaunissement de la peau et des yeux est le principal symptôme à surveiller."
}
},
{
"@type": "Question",
"name": "Quels examens complémentaires sont utiles ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des échographies ou des tests hépatiques peuvent aider à identifier la cause."
}
},
{
"@type": "Question",
"name": "L'hyperbilirubinémie est-elle toujours symptomatique ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, certaines personnes peuvent avoir des niveaux élevés sans symptômes visibles."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants de l'hyperbilirubinémie ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent jaunisse, fatigue, démangeaisons et urine foncée."
}
},
{
"@type": "Question",
"name": "L'hyperbilirubinémie peut-elle causer des démangeaisons ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'accumulation de bilirubine peut provoquer des démangeaisons cutanées."
}
},
{
"@type": "Question",
"name": "Comment l'urine change-t-elle en cas d'hyperbilirubinémie ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'urine peut devenir foncée, semblable à celle du thé, en raison de la bilirubine."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des douleurs abdominales ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs abdominales peuvent survenir si la cause est liée à des problèmes hépatiques."
}
},
{
"@type": "Question",
"name": "L'hyperbilirubinémie affecte-t-elle la vision ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle n'affecte généralement pas la vision, mais le jaunissement des yeux peut être visible."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'hyperbilirubinémie ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter l'alcool et les hépatites virales peut réduire le risque d'hyperbilirubinémie."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles utiles ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, se faire vacciner contre l'hépatite A et B peut prévenir certaines causes."
}
},
{
"@type": "Question",
"name": "Faut-il surveiller les nouveau-nés ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les nouveau-nés doivent être surveillés pour détecter une hyperbilirubinémie précoce."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut soutenir la santé hépatique et prévenir des problèmes."
}
},
{
"@type": "Question",
"name": "Les examens réguliers sont-ils importants ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des examens réguliers peuvent aider à détecter des problèmes hépatiques précocement."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour l'hyperbilirubinémie ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement dépend de la cause sous-jacente, comme des médicaments ou une photothérapie."
}
},
{
"@type": "Question",
"name": "La photothérapie est-elle efficace ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la photothérapie est souvent utilisée pour traiter l'hyperbilirubinémie chez les nouveau-nés."
}
},
{
"@type": "Question",
"name": "Quand faut-il envisager une transfusion sanguine ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une transfusion peut être nécessaire si les niveaux de bilirubine sont très élevés et menaçants."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des médicaments peuvent traiter des causes spécifiques comme l'hépatite ou l'anémie."
}
},
{
"@type": "Question",
"name": "Y a-t-il des remèdes naturels ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains remèdes naturels peuvent aider, mais il est essentiel de consulter un médecin."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des lésions hépatiques, des troubles neurologiques et des infections."
}
},
{
"@type": "Question",
"name": "L'hyperbilirubinémie peut-elle causer des dommages cérébraux ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux très élevés de bilirubine peuvent entraîner des dommages cérébraux, surtout chez les bébés."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque de cirrhose ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une hyperbilirubinémie chronique peut contribuer au développement de la cirrhose."
}
},
{
"@type": "Question",
"name": "Peut-elle entraîner des infections ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles hépatiques peuvent augmenter le risque d'infections opportunistes."
}
},
{
"@type": "Question",
"name": "Quels sont les risques à long terme ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les risques à long terme incluent des maladies hépatiques chroniques et des complications systémiques."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque d'hyperbilirubinémie ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des maladies hépatiques, des infections et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les nouveau-nés et les personnes âgées sont plus à risque d'hyperbilirubinémie."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de maladies hépatiques ou d'anémie augmentent le risque."
}
},
{
"@type": "Question",
"name": "Le sexe a-t-il un impact ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent que les hommes peuvent être plus à risque que les femmes."
}
},
{
"@type": "Question",
"name": "Les habitudes de vie influencent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des habitudes comme la consommation d'alcool et le tabagisme augmentent le risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 22/03/2026
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Publications dans "Hyperbilirubinémie" :
2 publications dans cette catégorie
Publications dans "Hyperbilirubinémie" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatrics, Seattle Children's Hospital, Seattle, Washington; Departments of pearlchangmd@gmail.com.
Publications dans "Hyperbilirubinémie" :
2 publications dans cette catégorie
Affiliations :
Liver Brain Unit "Rita Moretti", Fondazione Italiana Fegato-Onlus, Bldg. Q, AREA Science Park, 34149 Basovizza, Italy.
Publications dans "Hyperbilirubinémie" :
2 publications dans cette catégorie
Affiliations :
Neonatology Division, Department of Pediatrics, Cipto Mangunkusumo Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, 10430, Indonesia.
Publications dans "Hyperbilirubinémie" :
2 publications dans cette catégorie
Affiliations :
Neonatology Division, Department of Child Health, Faculty of Medicine Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, 55281, Indonesia.
Publications dans "Hyperbilirubinémie" :
1 publication dans cette catégorie
Affiliations :
Queen's School of Medicine, Queen's University, Kingston, ON, Canada.
Publications dans "Hyperbilirubinémie" :
1 publication dans cette catégorie
Affiliations :
Department of Pediatrics, Queen's University, Kingston, ON, Canada.
Publications dans "Hyperbilirubinémie" :
1 publication dans cette catégorie
Publications dans "Hyperbilirubinémie" :
1 publication dans cette catégorie
Publications dans "Hyperbilirubinémie" :
1 publication dans cette catégorie
Affiliations :
Department of Pediatrics, Division of Neonatology and Developmental Biology, Neonatal Research Center of the UCLA Children's Discovery and Innovation Institute, David Geffen School of Medicine UCLA, Los Angeles, CA.
Publications dans "Hyperbilirubinémie" :
1 publication dans cette catégorie
Affiliations :
Department of Pediatric Surgery, John R. Oishei Children's Hospital, 1001 Main Street, Buffalo, NY, 14203, USA.
Publications dans "Hyperbilirubinémie" :
1 publication dans cette catégorie
Affiliations :
Department of Pediatrics, John R. Oishei Children's Hospital, Buffalo, USA.
Publications dans "Hyperbilirubinémie" :
1 publication dans cette catégorie
Affiliations :
Department of Pediatrics, John R. Oishei Children's Hospital, Buffalo, USA.
Department of Pediatrics, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, USA.
Publications dans "Hyperbilirubinémie" :
1 publication dans cette catégorie
Affiliations :
Department of Nutrition, John R. Oishei Children's Hospital, Buffalo, USA.
Publications dans "Hyperbilirubinémie" :
1 publication dans cette catégorie
Affiliations :
Department of Pediatric Surgery, John R. Oishei Children's Hospital, 1001 Main Street, Buffalo, NY, 14203, USA. drothstein@kaleidahealth.org.
Department of Surgery, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY, USA. drothstein@kaleidahealth.org.
Publications dans "Hyperbilirubinémie" :
1 publication dans cette catégorie
Affiliations :
Faculty of Medicine, Department of Otorhinolaryngology, Benha University, Benha Faculty of Medicine, Egypt. Electronic address: ghader_massoud@yahoo.com.
Publications dans "Hyperbilirubinémie" :
1 publication dans cette catégorie
Affiliations :
Faculty of Medicine, Department of Otorhinolaryngology, Benha University, Benha Faculty of Medicine, Egypt. Electronic address: drmohamedalyelsayed@yahoo.com.
Publications dans "Hyperbilirubinémie" :
1 publication dans cette catégorie
Affiliations :
Faculty of Medicine, Department of Audio Vestibular Medicine, Mansoura University, Mansoura Faculty of Medicine, Egypt. Electronic address: ashraf_morgan75@yahool.com.
Publications dans "Hyperbilirubinémie" :
1 publication dans cette catégorie
Affiliations :
Faculty of Medicine, Department of Otorhinolaryngology, Benha University, Benha Faculty of Medicine, Egypt. Electronic address: ghadeer_masoud@yahoo.com.
Publications dans "Hyperbilirubinémie" :
Cholestasis affects 2% of newborns admitted to the neonatal intensive care unit and 20% of premature infants and requires a thoughtful evaluation and diagnostic workup.There may be a single responsibl...
There is little information on the differential diagnosis and prognosis of hospitalized patients with hyperbilirubinemia. Here, we hypothesized that hyperbilirubinemia in hospitalized patients is asso...
According to statistics, hyperbilirubinemia is observed during the first week of life in approximately 60% of full-term and 80% of premature newborns. It is known that indirect bilirubin has a neuroto...
Neonatal hyperbilirubinemia (NHb) results from increased total serum bilirubin and is a common reason for admission and readmission amongst newborn infants born in North America. The use of intravenou...
Using national and provincial databases, a population-based retrospective cohort study of infants born in Ontario from April 2014 to March 2018 was conducted....
Of the 533,084 infants born in Ontario at ≥35 weeks gestation, 29,756 (5.6%) presented with NHb. Among these infants, 80.1-88.2% received phototherapy, 1.1-2.0% received IVIG therapy and 0.1-0.2% rece...
IVIG therapy is increasingly being used in Ontario despite limited studies evaluating its use. The results of this study could inform treatment and management protocols for NHb....
Clinically significant neonatal hyperbilirubinemia still occurs in Ontario, with an increasing number of infants receiving Intravenous Immunoglobulin G (IVIG) therapy. IVIG continues to be used at inc...
We aimed to evaluate the effect of hyperbilirubinemia and phototherapy on total apoptotic, platelet-derived, endothelial-derived, and tissue factor (TF)-positive apoptotic microparticle (MP) levels in...
Thirty-three term neonates with nonhemolytic pathologic hyperbilirubinemia and 25 healthy term neonates were included. MP levels were analyzed by flow cytometry using peripheral blood samples only onc...
The rates of total apoptotic and endothelial-derived apoptotic MPs were significantly higher in the study group than the control group before phototherapy (P = 0.012 and P = 0.003, respectively) and a...
Our study demonstrated that total apoptotic and endothelial-derived apoptotic MPs are increased in cases of nonhemolytic pathologic hyperbilirubinemia. We showed that phototherapy does not have a sign...
Bilirubin was supposed to have cardio-metabolic protective role by signaling functions. Indeed, mild hyperbilirubinemia has immunosuppressive and endocrine activities and may offer protection against ...
To investigate the prevalence of hyperbilirubinemia and its cardio-metabolic effects in a cohort of elite Italian athletes engaged in different sports disciplines....
We enrolled 1492 elite athletes (age 25.8 ± 5.1) practising different disciplines (power, skills, endurance, and mixed) underwent blood, echocardiographic, and exercise tests. GS was diagnosed per exc...
GS was highlighted in 91 athletes (6%; globally 9% male and 2.4% female); 82% were males (p < 0.0001) showing higher indirect bilirubin (0.53 ± 0.4 vs. 0.36 ± 0.24 mg/dL in females, p < 0.0001). GS at...
Bilirubin has several metabolic effects (including immunosuppressive and endocrine) and plays a role in regulating antioxidant pathways exercise-related with hematological consequences but seems not t...
Few studies have provided data on the metabolomics characteristics of metabolic diseases such as hyperuricemia and hyperbilirubinemia in the Tibetan plateau. In the current study, we sought to investi...
Liver-related side effects are a known complication of treatment with elexacaftor/tezacaftor/ivacaftor (ETI) for cystic fibrosis (CF). Gilbert's syndrome is caused by a genetic mutation that reduces a...
Hyperbilirubinemia is a clinical picture frequently occurring in the neonatal period and may negatively affect the development of infants....
To evaluate term infants with hyperbilirubinemia in terms of both motor development and sensory processing skills and to compare them with their healthy peers without hyperbilirubinemia....
A cross-sectional study....
Children born at term, aged 10-18 months, with and without a history of hyperbilirubinemia were included in the study....
After demographic information was recorded, motor development was evaluated with the Peabody Motor Development Scale-2 and sensory processing skills were evaluated with the Test of Sensory Function in...
A total of 42 children (mean ± SD age of the children 13.07 ± 1.47 months, 22 with hyperbilirubinemia and 20 without hyperbilirubinemia) were included in the study. A statistically significant differe...
The motor and sensory processing skills of children born at term with hyperbilirubinemia may be negatively affected. Infants with hyperbilirubinemia should be evaluated from the early period not only ...
To describe the distribution of peak bilirubin levels among infants born before 29 weeks of gestation in the first 14 days of life and to study the association between quartiles of peak bilirubin leve...
Multicenter, retrospective, nationwide cohort study of neonatal intensive care units in the Canadian Neonatal Network and Canadian Neonatal Follow-Up Network, including neonates born preterm at 22...
Among 12 554 included newborns, median gestational age was 26 weeks (IQR 25-28) and birth weight was 920 g (IQR 750-1105 g). The median peak bilirubin values increased as gestational age increased (11...
In this multicenter cohort study, peak bilirubin levels in neonates of <29 weeks of gestation increased with gestational age. Peak bilirubin values in the highest gestational age-specific quartile wer...